Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ease of Use of Placebo ELLIPTA Inhaler in Asthma
NCT02586506Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2015
- Primary completion
- Feb 2016
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in asthma, sponsored by GSK. Primary endpoint: Percentage of Participants Who Rated the Use of the ELLIPTA Inhaler as Easy or Very Easy at 28 days. Started Oct 2015; status: completed.
02
Conditions
asthma
Beyond the preview
Go deeper on NCT02586506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02586506.